Misregulation of iron homeostasis in amyotrophic lateral sclerosis;Zaburzenie homeostazy żelaza w stwardnieniu zanikowym bocznym

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 70, Issue , 2016, Pages 709-721

  Gajowiak, Anna ^a   Styś, Agnieszka ^a   Starzyński, Rafał R ^a   Staroń, Robert ^a   Lipiński, Paweł ^a  

^a INSTITUTE OF GENETICS AND ANIMAL BREEDING   (Poland)

Author keywords

ALS; Brain; Iron; Motor neuron; Neurodegeneration; Oxidative stress; SOD1; Spinal cord

Indexed keywords

IRON; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL; CELL DEATH; CENTRAL NERVOUS SYSTEM; GENETICS; HOMEOSTASIS; HUMAN; METABOLISM; MOTONEURON; MUTATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELL DEATH; CENTRAL NERVOUS SYSTEM; HOMEOSTASIS; HUMANS; IRON; MOTOR NEURONS; MUTATION; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 85008879654     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.1208036     Document Type: Review

References (116)

1. Aisen P., Leibman A., Zweier J.: Stoichiometric and site characteristics of the binding of iron to human transferrin. J. Biol. Chem., 1978; 253: 1930-1937
2. Alexander J., Kowdley K.V.: HFE-associated hereditary hemochromatosis. Genet. Med., 2009;11: 307-313
3. Allen R.P., Earley C.J.: The role of iron in restless legs syndrome. Mov. Disord. 2007; 22: S440-S448
4. Andrews N.C.: Forging a field: the golden age of iron biology. Blood, 2008; 112: 219-230
5. Barber S.C., Mead R.J., Shaw P.J.: Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim. Biophys. Acta, 2006; 1762: 1051-1067
6. Bartosz G.: Druga twarz tlenu. Wydawnictwo Naukowe PWN, Warszawa 2003
7. Bartzokis G., Cummings J., Perlman S., Hance D.B., Mintz J.: Increased basal ganglia iron levels in Huntington disease. Arch. Neurol., 1999; 56: 569-574
8. Beard J.L.: Why iron deficiency is important in infant development. J. Nutr., 2008; 138: 2534-2536
9. Blasco H., Vourch P., Nadjar Y., Ribourtout B., Gordon P.H., Guettard Y.O., Camu W., Praline J., Meininger V., Andres C.R., Corcia P.: Association between divalent metal transport 1 encoding gene (SLC11A2) and disease duration in amyotrophic lateral sclerosis. J. Neurol. Sci., 2011; 303: 124-127
10. Brissot P., Ropert M., Le Lan C., Loréal O.: Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim. Biophys. Acta, 2012; 1820: 403-410
11. Bush A.I.: The metal theory of Alzheimer's disease. J. Alzheimers Dis., 2013; 33: S277-S281
12. Cammer W.: Oligodendrocyte associated enzymes. W: Oligodendroglia. red., W.T. Norton, New York: Plenum, 1984, 199-232
13. Cermák J., Neuwirt J.: A half century since the isolation of crystalline ferritin by Professor Laufberger. Vnitr. Lek., 1986; 32: 833-835
14. Charcot J.M., Joffroy A.: Deux cas d'atrophie musculaire progressive avec lesions de la substance grise et des faiseaux anterolateraux de la moelle epiniere. Arch. Physiol. Neurol. Pathol., 1869; 2: 744-754
15. Clark S.F.: Iron deficiency anemia: diagnosis and management. Curr. Opin. Gastroenterol. 2009; 25: 122-128
16. Cozzolino M., Ferri A., Valle C., Carrì M.T.: Mitochondria and ALS: implications from novel genes and pathways. Mol. Cell. Neurosci., 2013; 55: 44-49
17. Curtis A.R., Fey C., Morris C.M., Bindoff L.A., Ince P.G., Chinnery P.F., Coulthard A., Jackson M.J., Jackson A.P., McHale D.P., Hay D., Barker W.A., Markham A.F., Bates D., Curtis A., Burn J.: Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat. Genet., 2001; 28: 350-354
18. Danzeisen R., Achsel T., Bederke U., Cozzolino M., Crosio C., Ferri A., Frenzel M., Gralla E.B., Huber L., Ludolph A., Nencini M., Rotilio G., Valentine J.S., Carrì M.T.: Superoxide dismutase 1 modulates expression of transferrin receptor. J. Biol. Inorg. Chem., 2006; 11: 489-498
19. Dobrowolny G., Aucello M., Rizzuto E., Beccafico S., Mammucari C., Boncompagni S., Belia S., Wannenes F., Nicoletti C., Del Prete Z., Rosenthal N., Molinaro M., Protasi F., Fanò G., Sandri M., Musarò A.: Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab., 2008; 8: 425-436
20. Duce J.A., Tsatsanis A., Cater M.A., James S.A., Robb E., Wikhe K., Leong S.L., Perez K., Johanssen T., Greenough M.A., Cho H.H., Galatis D., Moir R.D., Masters C.L., McLean C. i wsp.: Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell, 2010; 142: 857-867
21. Ebrahimi K.H., Hagedoorn P.L., Hagen W.R.: A synthetic peptide with the putative iron binding motif of amyloid precursor protein (APP) does not catalytically oxidize iron. PLoS One, 2012; 7: e40287
22. Farquhar J., Zerkle A.L., Bekker A.: Geological constraints on the origin of oxygenic photosynthesis. Photosynth. Res., 2011; 107: 11-36
23. Friedman A., Gałazka-Friedman J.: The history of the research of iron in parkinsonian substantia nigra. J. Neural. Transm., 2012; 119: 1507-1510
24. G93A genes: a competent experimental model for studying iron metabolism in amyotrophic lateral sclerosis. Front. Mol. Neurosci., 2016; 8: 82
25. Galy B., Ferring D., Minana B., Bell O., Janser H.G., Muckenthaler M., Schümann K., Hentze M.W.: Altered body iron distribution and microcytosis in mice deficient in iron regulatory protein 2 (IRP2). Blood, 2005; 106: 2580-2589
26. Gladman M., Zinman L.: The economic impact of amyotrophic lateral sclerosis: a systematic review. Expert Rev. Pharmacoecon. Outcomes Res., 2015; 15: 439-450
27. Golub M.S., Germann S.L., Araiza R.S., Reader J.R., Griffey S.M., Lloyd K.C.: Movement disorders in the Hfe knockout mouse. Nutr. Neurosci., 2005; 8: 239-244
28. Goodall E.F., Haque M.S., Morrison K.E.: Increased serum ferritin levels in amyotrophic lateral sclerosis (ALS) patients. J. Neurol., 2008; 255: 1652-1656
29. Grantham-McGregor S., Ani C.: A review of studies on the effect of iron deficiency on cognitive development in children. J. Nutr., 2001; 131: 649S-666S
30. Grieb P.: Transgenic models of amyotrophic lateral sclerosis. Folia Neuropathol., 2004; 42: 239-248
31. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W, Deng H.X. i wsp.: Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science, 1994; 264: 1772-1775
32. Hadzhieva M., Kirches E., Mawrin C.: Review: iron metabolism and the role of iron in neurodegenerative disorders. Neuropathol. Appl. Neurobiol., 2014; 40: 240-57
33. Hadzhieva M., Kirches E., Wilisch-Neumann A., Pachow D., Wallesch M., Schoenfeld P., Paege I., Vielhaber S., Petri S., Keilhoff G., Mawrin C.: Dysregulation of iron protein expression in the G93A model of amyotrophic lateral sclerosis. Neuroscience, 2013; 230: 94-101
34. Hadziahmetovic M., Song Y., Ponnuru P., Iacovelli J., Hunter A., Haddad N., Beard J., Connor J.R., Vaulont S., Dunaief J.L.: Age-dependent retinal iron accumulation and degeneration in hepcidin knockout mice. Invest. Ophthalmol. Vis. Sci., 2011; 52: 109-118
35. Hallgren B., Sourander P.: The effect of age on the non-haemin iron in the human brain. J. Neurochem., 1958; 3: 41-51
36. Halon M., Kaczor J.J., Ziółkowski W., Flis D.J., Borkowska A., Popowska U., Nyka W., Wozniak M., Antosiewicz J.: Changes in skeletal muscle iron metabolism outpace amyotrophic lateral sclerosis onset in transgenic rats bearing the G93A hmSOD1 gene mutation. Free Radic. Res., 2014; 48: 1363-1370
37. Halon M., Sielicka-Dudzin A., Wozniak M., Ziolkowski W., Nyka W., Herbik M., Grieb P., Figarski A., Antosiewicz J.: Up-regulation of ferritin ubiquitination in skeletal muscle of transgenic rats bearing the G93A hmSOD1 gene mutation. Neuromuscul. Disord., 2010; 20: 29-33
38. Harrison P.M., Arosio P.: The ferritins: molecular properties, iron storage function and cellular regulation. Biochim. Biophys. Acta, 1996; 1275: 161-203
39. Haverkamp L.J., Appel V., Appel S.H.: Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain, 1995; 118: 707-719
40. Hebbrecht G., Maenhaut W., De Reuck J.: Brain trace elements and aging. Nucl. Instrum. Methods Phys. Res., 1999; 150: 208-213
41. Henderson B.R., Seiser C., Kühn L.C.: Characterization of a second RNA-binding protein in rodents with specificity for iron-responsive elements. J. Biol. Chem., 1993; 268: 27327-27334
42. Ignjatović A., Stević Z., Lavrnić S., Daković M., Bačić G.: Brain iron MRI: a biomarker for amyotrophic lateral sclerosis. J. Magn. Reson. Imaging., 2013; 38: 1472-1479
43. Ikeda K., Hirayama T., Takazawa T., Kawabe K., Iwasaki Y.: Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: a cross-sectional study. Intern. Med., 2012; 51: 1501-1508
44. Jeong S.Y., Crooks D.R., Wilson-Ollivierre H., Ghosh M.C., Sougrat R., Lee J., Cooperman S., Mitchell J.B., Beaumont C., Rouault T.A.: Iron insufficiency compromises motor neurons and their mitochondrial function in Irp2-null mice. PLoS One, 2011; 6: e25404
45. Jeong S.Y., Rathore K.I., Schulz K., Ponka P., Arosio P., David S.: Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis. J. Neurosci., 2009; 29: 610-619
46. Jiménez A.J., Domínguez-Pinos M.D., Guerra M.M., Fernández-Llebrez P., Pérez-Fígares J.M.: Structure and function of the ependymal barrier and diseases associated with ependyma disruption. Tissue Barriers, 2014; 2: e28426
47. Kasarskis E.J., Tandon L., Lovell M.A., Ehmann W.D.: Aluminum, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy: a preliminary study. J. Neurol. Sci., 1995; 130: 203-208
48. Keep R.F., Jones H.C.: A morphometric study on the development of the lateral ventricle choroid plexus, choroid plexus capillaries and ventricular ependyma in the rat. Brain Res. Dev. Brain Res., 1990; 56: 47-53
49. Krawiec P., Pac-Kozuchowska E.: The role of hepcidin in iron metabolism in inflammatory bowel diseases. Postȩpy Hig. Med. Dośw., 2014; 68: 936-943
50. Kruszewski M.: Labile iron pool: the main determinant of cellular response to oxidative stress. Mutat. Res., 2003; 531: 81-92
51. Kupershmidt L., Weinreb O., Amit T., Mandel S., Carri M.T., Youdim M.B.: Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis. FASEB J., 2009; 23: 3766-3779
52. Kwan J.Y., Jeong S.Y., Van Gelderen P., Deng H.X., Quezado M.M., Danielian L. E., Butman J.A., Chen L., Bayat E., Russell J., Siddique T., Duyn J.H., Rouault T.A., Floeter M.K.: Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology. PLoS One, 2012; 7: e35241
53. Lai C.H., Kuo K.H.: The critical component to establish in vitro BBB model: pericyte. Brain Res. Brain Res. Rev., 2005; 50: 258-265
54. Lambert J.F., Beris P.: Pathophysiology and different diagnosis of anemia. W: Disorders of iron homeostasis, erythrocytes, erythropoiesis. Red.: C. Beaumont, P. Beris, Y. Beuzard. C. Brugnara. Eur. School Haematology, Paris. 2006; 73-101
55. LaVaute T., Smith S., Cooperman S., Iwai K., Land W., Meyron-Holtz E., Drake S.K., Miller G., Abu-Asab M., Tsokos M., Switzer R. III, Grinberg A., Love P., Tresser N., Rouault T.A.: Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat. Genet., 2001; 27: 209-214
56. Leitner D.F., Connor J.R.: Functional roles of transferrin in the brain. Biochim. Biophys. Acta, 2012; 1820: 393-402
57. Levi S., Corsi B., Bosisio M., Invernizzi R., Volz A., Sanford D., Arosio P., Drysdale J.: A human mitochondrial ferritin encoded by an intronless gene. J. Biol. Chem., 2001; 276: 24437-24440
58. Ling S.C., Polymenidou M., Cleveland D.W.: Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron, 2013; 79: 416-38
59. Lipiński P., Starzyński R.R.: Regulation of body iron homeostasis by hepcidin. Postȩpy Hig. Med. Dośw., 2004; 58: 65-73
60. Lipiński P., Starzyński R.R.: The role of iron regulatory proteins (IRPs) in the regulation of systemic iron homeostasis: lessons from studies on IRP1 and IRP2 knock out mice. Postȩpy Hig. Med. Dośw., 2006; 60: 322-330
61. Lipiński P., Starzyński R.R., Styś A., Gajowiak A., Staroń R.: Heme metabolism as an integral part of iron homeostasis. Postȩpy Hig. Med. Dośw., 2014; 68: 557-570
62. Lipiński P., Starzyński R.R., Styś A., Straciło M.: Iron homeostasis, a defense mechanism in oxidative stress. Postȩpy Biochem., 2010; 56: 305-316
63. Lipiński P., Styś A., Starzyński R.R.: Molecular insights into the regulation of iron metabolism during the prenatal and early postnatal periods. Cell. Mol. Life Sci., 2013; 70: 23-38
64. Lozoff B., Georgieff M.K.: Iron deficiency and brain development. Semin. Pediatr. Neurol., 2006; 13: 158-165
65. Lozoff B., Jimenez E., Smith J.B.: Double burden of iron deficiency in infancy and low socioeconomic status: a longitudinal analysis of cognitive test scores to age 19 years. Arch. Pediatr. Adolesc. Med., 2006; 160: 1108-1113
66. Maktabi M.A., Heistad D.D., Faraci F.M.: Effects of angiotensin II on blood flow to choroid plexus. Am. J. Physiol., 1990; 258: H414-H418
67. Massignan T., Casoni F., Basso M., Stefanazzi P., Biasini E., Tortarolo M., Salmona M., Gianazza E., Bendotti C., Bonetto V.: Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse. Biochem. Biophys. Res. Commun., 2007; 353: 719-725
68. McCarthy R.C., Kosman D.J.: Ferroportin and exocytoplasmic ferroxidase activity are required for brain microvascular endothelial cell iron efflux. J. Biol. Chem., 2013; 288: 17932-17940
69. McCarthy R.C., Kosman D.J.: Glial cell ceruloplasmin and hepcidin differentially regulate iron efflux from brain microvascular endothelial cells. PLoS One, 2014; 9: e89003
70. McCarthy R.C., Kosman D.J.: Iron transport across the blood-brain barrier: development, neurovascular regulation and cerebral amyloid angiopathy. Cell. Mol. Life Sci., 2015; 72: 709-727
71. McCord J.M., Fridovich I.: Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem., 1969; 244: 6049-6055
72. McKie A.T.: The role of Dcytb in iron metabolism: an update. Biochem. Soc. Trans., 2008; 36: 1239-1241
73. Mitchell R.M., Simmons Z., Beard J.L., Stephens H.E., Connor J.R.: Plasma biomarkers associated with ALS and their relationship to iron homeostasis. Muscle Nerve, 2010; 42: 95-103
74. Moos T.: Immunohistochemical localization of intraneuronal transferrin receptor immunoreactivity in the adult mouse central nervous system. J. Comp. Neurol., 1996; 375: 675-692
75. Moos T., Skjoerringe T., Gosk S., Morgan E.H.: Brain capillary endothelial cells mediate iron transport into the brain by segregating iron from transferrin without the involvement of divalent metal transporter 1. J. Neurochem., 2006; 98: 1946-1958
76. Musarò A.: Understanding ALS: new therapeutic approaches. FEBS J., 2013; 280: 4315-4322
77. Musci G., Polticelli F., Bonaccorsi di Patti M.C.: Ceruloplasmin-ferroportin system of iron traffic in vertebrates. World J. Biol. Chem., 2014; 5: 204-215
78. Nadjar Y., Gordon P., Corcia P., Bensimon G., Pieroni L., Meininger V., Salachas F.: Elevated serum ferritin is associated with reduced survival in amyotrophic lateral sclerosis. PLoS One, 2012; 7: e45034
79. Nagańska E., Matyja E.: Amyotrophic lateral sclerosis - looking for pathogenesis and effective therapy. Folia Neuropathol., 2011; 49: 1-13
80. Nandar W., Neely E.B., Simmons Z., Connor J.R.: H63D HFE gen721 otype accelerates disease progression in animal models of amyotrophic lateral sclerosis. Biochim. Biophys. Acta, 2014; 1842: 2413-2426
81. Nicolas G., Chauvet C., Viatte L., Danan J.L., Bigard X., Devaux I., Beaumont C., Kahn A., Vaulont S.: The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest., 2002; 110: 1037-1044
82. Oshiro S., Morioka M.S., Kikuchi M.: Dysregulation of iron metabolism in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Adv. Pharmacol. Sci., 2011; 2011: 378278
83. Oski F.A., Honig A.S., Helu B., Howanitz P.: Effect of iron therapy on behavior performance in nonanemic, iron-deficient infants. Pediatrics, 1983; 71: 877-880
84. Paradkar P.N., Zumbrennen K.B., Paw B.H., Ward D.M., Kaplan J.: Regulation of mitochondrial iron import through differential turnover of mitoferrin 1 and mitoferrin 2. Mol. Cell. Biol., 2009; 29: 1007-1016
85. Patel B.N., Dunn R.J., David S.: Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain. J. Biol. Chem., 2000; 275: 4305-4310
86. Petrak J., Vyoral D.: Hephaestin - a ferroxidase of cellular iron export. Int. J. Biochem. Cell. Biol., 2005; 37: 1173-1178
87. Ramos P., Santos A., Pinto N.R., Mendes R., Magalhaes T., Almeida A.: Iron levels in the human brain: a post-mortem study of anatomical region differences and age-related changes. J. Trace Elem. Med. Biol., 2014; 28: 13-17
88. Renton A.E., Chiò A., Traynor B.J.: State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci., 2014; 17: 17-23
89. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X.: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 1993; 362: 59-62
90. Rouault T.A.: Iron metabolism in the CNS: implications for neurodegenerative diseases. Nat. Rev. Neurosci., 2013; 14: 551-564
91. Rouault T.A., Cooperman S.: Brain iron metabolism. Semin. Pediatr. Neurol., 2006; 13: 142-148
92. Rouault T.A., Zhang D.L., Jeong S.Y.: Brain iron homeostasis, the choroid plexus, and localization of iron transport proteins. Metab. Brain Dis., 2009; 24: 673-684
93. Schenck J.F.: Magnetic resonance imaging of brain iron. J. Neurol. Sci., 2003; 207: 99-102
94. Schulz K., Vulpe C.D., Harris L.Z., David S.: Iron efflux from oligodendrocytes is differentially regulated in gray and white matter. J. Neurosci., 2011; 31: 13301-13311
95. Skjørringe T., Møller L.B., Moos T.: Impairment of interrelated iron- and copper homeostatic mechanisms in brain contributes to the pathogenesis of neurodegenerative disorders. Front. Pharmacol., 2012; 3: 169
96. + conductance in rat choroid plexus epithelial cells. Am. J. Physiol. Cell. Physiol. 2004; 286: C611-C620
97. Sreedharan J., Brown R.H. Jr.: Amyotrophic lateral sclerosis: problems and prospects. Ann. Neurol., 2013; 74: 309-316
98. Staroń R., Styś A., Starzyński R., Gajowiak A., Lipiński P.: Enterocyt - waskie gardło metabolizmu żelaza. Postȩpy Biol. Kom., 2015; 42: 329-350
99. Styś A., Starzyński R.R., Lipiński P.: The role of iron regulatory proteins in the control of iron metabolism in mammals. Biotechnologia, 2011; 92: 66-75
100. Takeda A., Devenyi A., Connor J.R.: Evidence for non-transferrin-mediated uptake and release of iron and manganese in glial cell cultures from hypotransferrinemic mice. J. Neurosci. Res., 1998; 51: 454-462
101. Todorich B., Pasquini J.M., Garcia C.I., Paez P.M., Connor J.R.: Oligodendrocytes and myelination: the role of iron. Glia, 2009; 57: 467-748
102. Tomik B.: Diagnosis and treatment of amyotrophic lateral sclerosis according to EFNS recommendations (2005). Neurol. Neurochir. Pol., 2007; 41: 445-456
103. Turner B.J., Talbot K.: Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog. Neurobiol., 2008; 85: 94-134
104. Urrutia P., Aguirre P., Esparza A., Tapia V., Mena N.P., Arredondo M., González-Billault C., Núñez MT.: Inflammation alters the expression of DMT1, FPN1 and hepcidin and it causes iron accumulation in central nervous system cells. J. Neurochem., 2013; 126: 541-549
105. van Rheenen W., Diekstra F.P., van Doormaal P.T., Seelen M., Kenna K., McLaughlin R., Shatunov A., Czell D., van Es M.A., van Vught P.W., van Damme P., Smith B.N., Waibel S., Schelhaas H.J., van der Kooi A.J. i wsp.: H63D polymorphism in HFE is not associated with amyotrophic lateral sclerosis. Neurobiol. Aging, 2013; 34: 1517.e5-e7
106. Vaubel R.A., Isaya G.: Iron-sulfur cluster synthesis, iron homeostasis and oxidative stress in Friedreich ataxia. Mol. Cell. Neurosci., 2013; 55: 50-61
107. Veyrat-Durebex C., Corcia P., Mucha A., Benzimra S., Mallet C., Gendrot C., Moreau C., Devos D., Piver E., Pagès J.C., Maillot F., Andres C.R., Vourc'h P., Blasco H.: Iron metabolism disturbance in a French cohort of ALS patients. Biomed. Res. Int., 2014; 2014: 485723
108. Wang Q., Zhang X., Chen S., Zhang X., Zhang S., Youdium M., Le W.: Prevention of motor neuron degeneration by novel iron chelators in SOD1(G93A) transgenic mice of amyotrophic lateral sclerosis. Neurodegener. Dis., 2011; 8: 310-321
109. Wang W., Knovich M.A., Coffman L.G., Torti F.M., Torti S.V.: Serum ferritin: past, present and future. Biochim. Biophys. Acta, 2010; 1800: 760-769
110. Ward D.M., Kaplan J.: Ferroportin-mediated iron transport: expression and regulation. Biochim. Biophys. Acta, 2012; 1823: 1426-1433
111. Wong B.X., Tsatsanis A., Lim L.Q., Adlard P.A., Bush A.I., Duce J.A.: β-Amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin. PLoS One, 2014; 9: e114174
112. Xu X., Pin S., Gathinji M., Fuchs R., Harris Z.L.: Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Ann. N.Y. Acad. Sci., 2004; 1012: 299-305
113. Yu J., Qi F., Wang N., Gao P., Dai S., Lu Y., Su Q., Du Y., Che F.: Increased iron level in motor cortex of amyotrophic lateral sclerosis patients: an in vivo MR study. Amyotroph. Lateral Scler. Frontotemporal Degener., 2014; 15: 357-361
114. Zahs K.R., Bigornia V., Deschepper C.F.: Characterization of "plasma proteins" secreted by cultured rat macroglial cells. Glia, 1993; 7: 121-133
115. Zecca L., Stroppolo A., Gatti A., Tampellini D., Toscani M., Gallorini M., Giaveri G., Arosio P., Santambrogio P., Fariello R.G., Karatekin E., Kleinman M.H., Turro N., Hornykiewicz O., Zucca F.A.: The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc. Natl. Acad. Sci. USA, 2004; 101: 9843-9848
116. Zechel S., Huber-Wittmer K., von Bohlen und Halbach O.: Distribution of the iron-regulating protein hepcidin in the murine central nervous system. J. Neurosci. Res., 2006; 84: 790-800